Select Publications
Journal articles
2017, 'The distribution of epidermolysis bullosa in Australia with a focus on rural and remote areas', Australasian Journal of Dermatology, 58, pp. 122 - 125, http://dx.doi.org/10.1111/ajd.12431
,2017, 'A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patients', British Journal of Dermatology, 176, pp. 985 - 992, http://dx.doi.org/10.1111/bjd.15271
,2017, 'The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa', Journal of the European Academy of Dermatology and Venereology, 31, pp. 692 - 698, http://dx.doi.org/10.1111/jdv.13953
,2017, 'Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis', Annals of the Rheumatic Diseases, 76, pp. 543 - 546, http://dx.doi.org/10.1136/annrheumdis-2016-210002
,2017, 'Increasing prevalence but not incidence of psoriasis in the U.K.', British Journal of Dermatology, 176, pp. 568 - 569, http://dx.doi.org/10.1111/bjd.15331
,2017, 'Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease – specific Autoimmune Bullous Disease Quality of Life (ABQOL) and the Treatment Autoimmune Bullous Disease Quality of Life (TABQOL) questionnaires', Advances in Medical Sciences, 62, pp. 92 - 96, http://dx.doi.org/10.1016/j.advms.2016.07.002
,2017, 'Retrospective evidence on outcomes and experiences of pregnancy and childbirth in epidermolysis bullosa in Australia and New Zealand', International Journal of Women's Dermatology, 3, pp. S1 - S5, http://dx.doi.org/10.1016/j.ijwd.2017.02.002
,2017, 'Reliability and validity of the Chinese version of the autoimmune bullous disease quality of life (ABQOL) questionnaire', Health and Quality of Life Outcomes, 15, pp. 31, http://dx.doi.org/10.1186/s12955-017-0594-z
,2017, 'The reliability, validity and responsiveness of two disease scores (BPDAI and ABSIS) for bullous pemphigoid: Which one to use?', Acta Dermato-Venereologica, 97, pp. 24 - 31, http://dx.doi.org/10.2340/00015555-2473
,2017, 'Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score', Allergy: European Journal of Allergy and Clinical Immunology, 72, pp. 1713 - 1719, http://dx.doi.org/10.1111/all.13189
,2017, 'Why have hospitalization rates for bullous pemphigoid soared?', British Journal of Dermatology, 176, pp. 5 - 6, http://dx.doi.org/10.1111/bjd.15190
,2017, '012 Crisaborole ointment provides early relief of pruritus in two phase 3 clinical trials in patients with mild or moderate atopic dermatitis', Journal of Investigative Dermatology, 137, pp. S194 - S194, http://dx.doi.org/10.1016/j.jid.2017.07.108
,2017, 'To the Associate Editors and Reviewers of the International Journal of Women’s Dermatology and the Board of Directors of the Women’s Dermatologic Society', International Journal of Women's Dermatology, 3, pp. 1 - 2, http://dx.doi.org/10.1016/j.ijwd.2017.01.008
,2016, 'A lesson learned about predatory journals and their difference from peer-reviewed open-access publishing', International Journal of Women's Dermatology, 2, pp. 113 - 114, http://dx.doi.org/10.1016/j.ijwd.2016.08.004
,2016, 'Clinical application of a molecular assay for the detection of dermatophytosis and a novel non-invasive sampling technique', Pathology, 48, pp. 720 - 726, http://dx.doi.org/10.1016/j.pathol.2016.08.006
,2016, 'Validation studies of outcome measures in pemphigus', International Journal of Women's Dermatology, 2, pp. 128 - 139, http://dx.doi.org/10.1016/j.ijwd.2016.10.003
,2016, 'Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management', Drugs and Aging, 33, pp. 711 - 723, http://dx.doi.org/10.1007/s40266-016-0402-1
,2016, 'Patient and practitioner satisfaction with tele-dermatology including Australia's indigenous population: A systematic review of the literature', International Journal of Women's Dermatology, 2, pp. 70 - 73, http://dx.doi.org/10.1016/j.ijwd.2016.06.004
,2016, 'Blistering diseases in neonates', Current Opinion in Pediatrics, 28, pp. 500 - 506, http://dx.doi.org/10.1097/MOP.0000000000000381
,2016, 'Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia', Australasian Journal of Dermatology, 57, pp. 167 - 174, http://dx.doi.org/10.1111/ajd.12354
,2016, 'Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus', British Journal of Dermatology, 175, pp. 142 - 149, http://dx.doi.org/10.1111/bjd.14405
,2016, 'Neonatal autoimmune blistering disease: A systematic review', Pediatric Dermatology, 33, pp. 367 - 374, http://dx.doi.org/10.1111/pde.12859
,2016, 'Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)', British Journal of Dermatology, 175, pp. 69 - 79, http://dx.doi.org/10.1111/bjd.14773
,2016, 'Approach and Management of Autoimmune Blistering Diseases', Current Dermatology Reports, 5, pp. 105 - 114, http://dx.doi.org/10.1007/s13671-016-0140-y
,2016, 'Colchicine may assist in reducing granulation tissue in junctional epidermolysis bullosa', International Journal of Women's Dermatology, 2, pp. 56 - 59, http://dx.doi.org/10.1016/j.ijwd.2016.04.001
,2016, 'Epidermolysis bullosa - Why does a multidisciplinary team approach matter?', Turk Dermatoloji Dergisi, 10, pp. 70 - 77, http://dx.doi.org/10.4274/tdd.2986
,2016, 'Saggy skin as a presenting sign of angioimmunoblastic T-cell lymphoma', Clinical and Experimental Dermatology, 41, pp. 386 - 389, http://dx.doi.org/10.1111/ced.12773
,2016, 'What is the true mortality from pemphigus?', British Journal of Dermatology, 174, pp. 1185 - 1186, http://dx.doi.org/10.1111/bjd.14711
,2016, 'Cover image: Unpeeling the layers of harlequin ichthyosis', British Journal of Dermatology, 174, pp. 1160 - 1161, http://dx.doi.org/10.1111/bjd.14469
,2016, 'Debilitating late outcomes of toxic epidermal necrolysis (TEN): Presentation of 2 cases', AUSTRALASIAN JOURNAL OF DERMATOLOGY, 57, pp. 84 - 84, http://dx.doi.org/10.1111/ajd.12480/pdf
,2016, 'Erratum to "Severity score indexes for blistering diseases" [Clin Dermatol 2011:30 108-113], DOI: 10.1016/j.clindermatol.2011.03.017', Clinics in Dermatology, 34, pp. 430 - 431, http://dx.doi.org/10.1016/j.clindermatol.2016.03.002
,2016, 'Marked intrafamilial phenotypic heterogeneity in dystrophic epidermolysis bullosa caused by inheritance of a mild dominant glycine substitution and a novel deep intronic recessive COL7A1 mutation', British Journal of Dermatology, 174, pp. 1122 - 1125, http://dx.doi.org/10.1111/bjd.14312
,2016, 'Over-expression of periostin is associated with clinical outcomes and poor prognosis in cutaneous squamous cell carcinoma', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 136, pp. S75 - S75, http://dx.doi.org/10.1016/j.jid.2016.02.456
,2016, 'A review of case-control studies on the risk factors for the development of autoimmune blistering diseases', Journal of the European Academy of Dermatology and Venereology, 30, pp. 595 - 603, http://dx.doi.org/10.1111/jdv.13386
,2016, 'The quality of dermatology consultation documentation in discharge summaries: a retrospective analysis', International Journal of Women's Dermatology, 2, pp. 23 - 27, http://dx.doi.org/10.1016/j.ijwd.2015.12.003
,2016, 'Post Hoc analyses of the effect of crisaborole topical ointment, 2% on atopic dermatitis: Associated pruritus from phase 1 and 2 clinical studies', Journal of Drugs in Dermatology, 15, pp. 172 - 176
,2016, 'Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian Portuguese', International Journal of Dermatology, 55, pp. e94 - e99, http://dx.doi.org/10.1111/ijd.12819
,2016, 'Treatment of face and scalp solar (actinic) keratosis with daylight-mediated photodynamic therapy is possible throughout the year in Australia: Evidence from a clinical and meteorological study', Australasian Journal of Dermatology, 57, pp. 24 - 28, http://dx.doi.org/10.1111/ajd.12295
,2016, 'Cover Image: The many faces of sarcoidosis', British Journal of Dermatology, 175, pp. 1111 - 1112, http://dx.doi.org/10.1111/bjd.14981
,2016, 'Differences in disease-specific quality of life in patients with actinic keratosis in Australia and Denmark', Acta Dermatovenerologica Croatica, 24, pp. 25 - 28, http://hrcak.srce.hr/file/230721
,2016, 'Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: Best clinical practice guidelines', British Journal of Dermatology, 174, pp. 56 - 67, http://dx.doi.org/10.1111/bjd.14104
,2016, 'Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC', Journal of the National Cancer Institute, 108, http://dx.doi.org/10.1093/jnci/djv293
,2015, 'Botulinum toxin A injection for chronic anal fissures and anal sphincter spasm improves quality of life in recessive dystrophic epidermolysis bullosa', International Journal of Women's Dermatology, 1, pp. 167 - 169, http://dx.doi.org/10.1016/j.ijwd.2015.08.002
,2015, 'Burden of disease scoring in epidermolysis bullosa', British Journal of Dermatology, 173, pp. 1357 - 1358, http://dx.doi.org/10.1111/bjd.14246
,2015, 'Genetic screening for human leukocyte antigen alleles prior to carbamazepine treatment', Journal of Clinical Neuroscience, 22, pp. 1992 - 1993, http://dx.doi.org/10.1016/j.jocn.2015.05.037
,2015, 'Crisaborole Topical Ointment 2% in Adults With Atopic Dermatitis: A Phase 2a, Vehicle-Controlled, Proof-of-Concept Study.', Journal of Drugs in Dermatology, 14, pp. 1108 - 1112
,2015, 'Fifty shades of yellow: A review of the xanthodermatoses', International Journal of Dermatology, 54, pp. 1109 - 1123, http://dx.doi.org/10.1111/ijd.12945
,2015, 'Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA', Quality of Life Research, 24, pp. 2257 - 2260, http://dx.doi.org/10.1007/s11136-015-0965-z
,2015, 'Blisters and erosions affecting the oral cavity, scalp, face, and trunk', Journal of the American Academy of Dermatology, 73, pp. e87 - e88, http://dx.doi.org/10.1016/j.jaad.2015.03.027
,2015, 'A pilot comparison study of four clinician-rated atopic dermatitis severity scales', British Journal of Dermatology, 173, pp. 488 - 497, http://dx.doi.org/10.1111/bjd.13846
,